The anti-cancer effect of amygdalin on human cancer cell lines
Derived from rosaceous plant seed, amygdalin belongs to aromatic cyanogenic glycoside group, and its anticancer effects have been supported by mounting evidence. In this study, we objected to investigate amygdalin effect on two antiapoptotic genes (Survivin, XIAP) and two lncRNAs (GAS5, MALAT1) in human cancer cells (A549, MCF7, AGS). Employing RT-qPCR analysis, we compared the mRNA levels of the genes related to apoptosis in A549, MCF7, and AGS cancer cells between amygdalin-treated (24, 48 and 72 h) and un-treated groups. RNA was extracted from both cell groups and then cDNAs were synthesized. The changes in the gene expression levels were specified using ΔΔCt method. RT-qPCR analysis has revealed that the expression of Survivin, XIAP, GAS5 and MALAT1 in amygdala-treated cancer cells were significantly different, compared to the un-treated cells. However, these expressions were different depending on the treatment time. According to the results, amygdalin significantly inhibited the expression level of Survivin, and XIAP genes in treated via untreated group. Our findings suggest that amygdalin might have an anticancer effect due to the various gene expressions in A549, MCF7, and AGS human cancer cells, showing it’s potential as a natural therapeutic anticancer drug.
KeywordsAmygdalin Antiapoptotic genes LncRNAs Cancer cell line
Iran’s National Elites Foundation give this opportunity to graduate students to work on a scientific project instead of going to the military garrison. This manuscript is an outcome of military service project of first author (Mr. Asghar Arshi). Also, the authors would like to thank all the staff members of the Cellular and Molecular Research Center, Shahrekord University of Medical Sciences in Iran for their sincere support.
AA and SMH: Conceptualization; FH: Software; ZYA: Validation; FSH and ML: Formal analysis; SMH: Investigation; HK and MSD: Resources; AA and SMH: Writing-original draft preparation, Writing-review & editing; SMH: Supervision.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This article does not contain any studies with human participants performed by any of the authors.
- 1.Milazzo S, Ernst E, Lejeune S et al (2011) Laetrile treatment for cancer. In: Milazzo S (ed) Cochrane database of systematic reviews. Wiley, Chichester, p CD005476Google Scholar
- 7.Jaswal V, Palanivelu J, C R (2018) Effects of the Gut microbiota on amygdalin and its use as an anti-cancer therapy: substantial review on the key components involved in altering dose efficacy and toxicity. Biochem Biophys Rep 14:125–132. https://doi.org/10.1016/j.bbrep.2018.04.008 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Arshi A, Sharifi FS, Khorramian Ghahfarokhi M et al (2018) Expression analysis of MALAT1, GAS5, SRA and NEAT1 long non-coding RNAs in breast cancer tissues from young women and women over 45 years of age. Mol Ther-Nucleic Acids 12:751–757. https://doi.org/10.1016/J.OMTN.2018.07.014 CrossRefPubMedPubMedCentralGoogle Scholar